This website uses cookies. By using our website you consent to all cookies in accordance with our Privacy Policy. Read more - OK, thanks

Back to Latest News

Wednesday 3 December 2025
WAIDID Webinar: Evidence of the efficacy of the new monoclonal antibody nirsevimab against RSV infection

Watch the latest two part Webinar from WAIDID on The evidence of the efficacy of the new monoclonal antibody nirsevimab against RSV infection.